{"id":"grepafloxacin","rwe":[{"pmid":"38291012","year":"2024","title":"Reactive metabolite of trovafloxacin activates inflammasomes: Implications for trovafloxacin-induced liver injury.","finding":"","journal":"Journal of applied toxicology : JAT","studyType":"Clinical Study"},{"pmid":"34298344","year":"2021","title":"Monitoring of pharmaceuticals in aquatic biota (Procambarus clarkii) of the Doñana National Park (Spain).","finding":"","journal":"Journal of environmental management","studyType":"Clinical Study"},{"pmid":"32146702","year":"2020","title":"Fluoroquinolone-Induced Photosensitivity: A Chemical Fragment-Based Approach by a Case/Non-case Study in VigiBase(®).","finding":"","journal":"Drug safety","studyType":"Clinical Study"},{"pmid":"30086507","year":"2018","title":"Multiresidue determination of 21 pharmaceuticals in crayfish (Procambarus clarkii) using enzymatic microwave-assisted liquid extraction and ultrahigh-performance liquid chromatography-triple quadrupole mass spectrometry analysis.","finding":"","journal":"Journal of pharmaceutical and biomedical analysis","studyType":"Clinical Study"}],"tags":[{"label":"grepafloxacin","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Potassium voltage-gated channel subfamily H member 2","category":"target"},{"label":"KCNH2","category":"gene"},{"label":"J01MA11","category":"atc"},{"label":"Off-Patent","category":"patent"},{"label":"Active","category":"status"},{"label":"Acute Moraxella catarrhalis bronchitis","category":"indication"},{"label":"Acute bacterial bronchitis","category":"indication"},{"label":"Acute gonococcal cervicitis","category":"indication"},{"label":"Chlamydia Cervicitis","category":"indication"},{"label":"Gonorrhea","category":"indication"},{"label":"Haemophilus Influenzae Bronchitis","category":"indication"},{"label":"Otsuka","category":"company"},{"label":"Approved 1990s","category":"decade"},{"label":"Anti-Bacterial Agents","category":"pharmacology"},{"label":"Anti-Infective Agents","category":"pharmacology"},{"label":"Antineoplastic Agents","category":"pharmacology"},{"label":"Enzyme Inhibitors","category":"pharmacology"},{"label":"Topoisomerase II Inhibitors","category":"pharmacology"},{"label":"Topoisomerase Inhibitors","category":"pharmacology"}],"phase":"marketed","safety":{"drugInteractions":[{"url":"/drug/saquinavir","drug":"saquinavir","action":"Monitor closely","effect":"May interact with Grepafloxacin Hydrochloride, Saquinavir","source":"DrugCentral","drugSlug":"saquinavir"}]},"trials":[],"aliases":[],"company":"Otsuka","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=GREPAFLOXACIN","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T03:26:38.201223+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T03:26:46.450375+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=GREPAFLOXACIN","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T03:26:47.215207+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Topoisomerase IV inhibitor","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T03:26:47.858240+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200393/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T03:26:47.742320+00:00"}},"allNames":"tomefloxacin","offLabel":[],"synonyms":["grepafloxacin hydrochloride hydrate","grepafloxacin","tomefloxacin","grepafloxacin hydrochloride","grepafloxacin HCl"],"timeline":[{"date":"1997-11-06","type":"positive","source":"DrugCentral","milestone":"FDA approval (Otsuka)"}],"aiSummary":"Tomefloxacin, also known as Grepafloxacin, is a small molecule antibiotic developed by OTSUKA and approved by the FDA in 1997. It targets the potassium voltage-gated channel subfamily H member 2 and is used to treat various bacterial infections, including bronchitis, pneumonia, and gonorrhea. As an off-patent medication, it is no longer protected by active patents, but there are currently no generic manufacturers. The medication has a bioavailability of 70% and a half-life of 9.2 hours. It is used to treat a range of bacterial infections, but its commercial status is limited due to the lack of generic competition.","approvals":[{"date":"1997-11-06","orphan":false,"company":"OTSUKA","regulator":"FDA"}],"brandName":"Tomefloxacin","ecosystem":[{"indication":"Acute Moraxella catarrhalis bronchitis","otherDrugs":[{"name":"alatrofloxacin","slug":"alatrofloxacin","company":"Pfizer"},{"name":"cefaclor","slug":"cefaclor","company":""},{"name":"cefdinir","slug":"cefdinir","company":""},{"name":"cefpodoxime proxetil","slug":"cefpodoxime-proxetil","company":""}],"globalPrevalence":null},{"indication":"Acute bacterial bronchitis","otherDrugs":[{"name":"alatrofloxacin","slug":"alatrofloxacin","company":"Pfizer"},{"name":"azithromycin","slug":"azithromycin","company":""},{"name":"cefaclor","slug":"cefaclor","company":""},{"name":"cefixime","slug":"cefixime","company":""}],"globalPrevalence":null},{"indication":"Acute gonococcal cervicitis","otherDrugs":[{"name":"alatrofloxacin","slug":"alatrofloxacin","company":"Pfizer"},{"name":"amphotericin B","slug":"amphotericin-b","company":"Apothecon"},{"name":"ampicillin","slug":"ampicillin","company":"Wyeth Ayerst"},{"name":"azithromycin","slug":"azithromycin","company":""}],"globalPrevalence":null},{"indication":"Chlamydia Cervicitis","otherDrugs":[{"name":"alatrofloxacin","slug":"alatrofloxacin","company":"Pfizer"},{"name":"azithromycin","slug":"azithromycin","company":""},{"name":"erythromycin","slug":"erythromycin","company":"Arbor Pharms Llc"},{"name":"norfloxacin","slug":"norfloxacin","company":""}],"globalPrevalence":null},{"indication":"Gonorrhea","otherDrugs":[{"name":"amphotericin B","slug":"amphotericin-b","company":"Apothecon"},{"name":"ampicillin","slug":"ampicillin","company":"Wyeth Ayerst"},{"name":"bacampicillin","slug":"bacampicillin","company":""},{"name":"cefixime","slug":"cefixime","company":""}],"globalPrevalence":null},{"indication":"Haemophilus Influenzae Bronchitis","otherDrugs":[{"name":"alatrofloxacin","slug":"alatrofloxacin","company":"Pfizer"},{"name":"aztreonam","slug":"aztreonam","company":"Bristol Myers Squibb"},{"name":"cefaclor","slug":"cefaclor","company":""},{"name":"cefdinir","slug":"cefdinir","company":""}],"globalPrevalence":null},{"indication":"Haemophilus influenzae pneumonia","otherDrugs":[{"name":"alatrofloxacin","slug":"alatrofloxacin","company":"Pfizer"},{"name":"amoxicillin","slug":"amoxicillin","company":"Apothecon"},{"name":"ampicillin","slug":"ampicillin","company":"Wyeth Ayerst"},{"name":"azithromycin","slug":"azithromycin","company":""}],"globalPrevalence":null},{"indication":"Moraxella Catarrhalis Pneumonia","otherDrugs":[{"name":"alatrofloxacin","slug":"alatrofloxacin","company":"Pfizer"},{"name":"amoxicillin","slug":"amoxicillin","company":"Apothecon"},{"name":"azithromycin","slug":"azithromycin","company":""},{"name":"cefdinir","slug":"cefdinir","company":""}],"globalPrevalence":null}],"mechanism":{"target":"Potassium voltage-gated channel subfamily H member 2","novelty":"Follow-on","targets":[{"gene":"KCNH2","source":"DrugCentral","target":"Potassium voltage-gated channel subfamily H member 2","protein":"Potassium voltage-gated channel subfamily H member 2"}],"modality":"Small Molecule","drugClass":"grepafloxacin","explanation":"","oneSentence":"","technicalDetail":"Grepafloxacin is a fluoroquinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV, essential enzymes for bacterial DNA replication and transcription, leading to bacterial cell death."},"commercial":{"launchDate":"1997","_launchSource":"DrugCentral (FDA 1997-11-06, OTSUKA)"},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/1330","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=GREPAFLOXACIN","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=GREPAFLOXACIN","fields":["publications"],"source":"PubMed/NCBI"},{"id":4,"url":"https://www.fda.gov/drugs/drug-approvals-and-databases/orange-book-data-files","fields":["patents","exclusivity","genericManufacturers"],"source":"FDA Orange Book"}],"_enrichedAt":"2026-03-30T14:57:41.420254","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T03:26:49.640490+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"ofloxacin","drugSlug":"ofloxacin","fdaApproval":"1990-12-28","genericCount":20,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"ciprofloxacin","drugSlug":"ciprofloxacin","fdaApproval":"1987-10-22","patentExpiry":"Nov 27, 2038","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"enoxacin","drugSlug":"enoxacin","fdaApproval":"1991-12-31","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"norfloxacin","drugSlug":"norfloxacin","fdaApproval":"1986-10-31","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"lomefloxacin","drugSlug":"lomefloxacin","fdaApproval":"1992-02-21","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"sparfloxacin","drugSlug":"sparfloxacin","fdaApproval":"1996-12-19","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"levofloxacin","drugSlug":"levofloxacin","fdaApproval":"1996-12-20","genericCount":36,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"trovafloxacin","drugSlug":"trovafloxacin","fdaApproval":"1997-12-18","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"moxifloxacin","drugSlug":"moxifloxacin","fdaApproval":"1999-12-10","patentExpiry":"May 29, 2029","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"gemifloxacin","drugSlug":"gemifloxacin","fdaApproval":"2003-04-04","genericCount":1,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"gatifloxacin","drugSlug":"gatifloxacin","fdaApproval":"2003-03-28","genericCount":6,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"delafloxacin","drugSlug":"delafloxacin","fdaApproval":"2017-06-19","patentExpiry":"Sep 23, 2029","patentStatus":"Patent protected","relationship":"same-class"}],"genericName":"grepafloxacin","indications":{"approved":[{"name":"Acute Moraxella catarrhalis bronchitis","source":"DrugCentral","snomedId":195722003,"regulator":"FDA"},{"name":"Acute bacterial bronchitis","source":"DrugCentral","snomedId":233598009,"regulator":"FDA"},{"name":"Acute gonococcal cervicitis","source":"DrugCentral","snomedId":20943002,"regulator":"FDA"},{"name":"Chlamydia Cervicitis","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Gonorrhea","source":"DrugCentral","snomedId":15628003,"regulator":"FDA"},{"name":"Haemophilus Influenzae Bronchitis","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Haemophilus influenzae pneumonia","source":"DrugCentral","snomedId":70036007,"regulator":"FDA"},{"name":"Moraxella Catarrhalis Pneumonia","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Pneumonia due to Mycoplasma pneumoniae","source":"DrugCentral","snomedId":46970008,"regulator":"FDA"},{"name":"Pneumonia due to Streptococcus","source":"DrugCentral","snomedId":34020007,"regulator":"FDA"},{"name":"Streptococcus Pneumoniae Bronchitis","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Urethritis due to Chlamydia trachomatis","source":"DrugCentral","snomedId":179101003,"regulator":"FDA"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"patentStatus":"Off-patent — no active Orange Book patents","relatedDrugs":[{"drugId":"ofloxacin","brandName":"ofloxacin","genericName":"ofloxacin","approvalYear":"1990","relationship":"same-class"},{"drugId":"ciprofloxacin","brandName":"ciprofloxacin","genericName":"ciprofloxacin","approvalYear":"1987","relationship":"same-class"},{"drugId":"enoxacin","brandName":"enoxacin","genericName":"enoxacin","approvalYear":"1991","relationship":"same-class"},{"drugId":"norfloxacin","brandName":"norfloxacin","genericName":"norfloxacin","approvalYear":"1986","relationship":"same-class"},{"drugId":"lomefloxacin","brandName":"lomefloxacin","genericName":"lomefloxacin","approvalYear":"1992","relationship":"same-class"},{"drugId":"sparfloxacin","brandName":"sparfloxacin","genericName":"sparfloxacin","approvalYear":"1996","relationship":"same-class"},{"drugId":"levofloxacin","brandName":"levofloxacin","genericName":"levofloxacin","approvalYear":"1996","relationship":"same-class"},{"drugId":"trovafloxacin","brandName":"trovafloxacin","genericName":"trovafloxacin","approvalYear":"1997","relationship":"same-class"},{"drugId":"moxifloxacin","brandName":"moxifloxacin","genericName":"moxifloxacin","approvalYear":"1999","relationship":"same-class"},{"drugId":"gemifloxacin","brandName":"gemifloxacin","genericName":"gemifloxacin","approvalYear":"2003","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT02099240","phase":"EARLY_PHASE1","title":"Patients Response to Early Switch To Oral:Osteomyelitis Study","status":"TERMINATED","sponsor":"Julio Ramirez","startDate":"2014-03-06","conditions":["Osteomyelitis"],"enrollment":11,"completionDate":"2018-11-07"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"_patentsChecked":true,"crossReferences":{"NUI":"N0000022102","MMSL":"4802","NDDF":"007022","UNII":"L1M1U2HC31","VUID":"4024097","CHEBI":"CHEBI:5543","VANDF":"4021079","INN_ID":"7024","RXNORM":"236862","UMLSCUI":"C0287721","chemblId":"CHEMBL1200393","ChEMBL_ID":"CHEMBL583","KEGG_DRUG":"D02178","DRUGBANK_ID":"DB00365","PUBCHEM_CID":"72474","SNOMEDCT_US":"108679003","IUPHAR_LIGAND_ID":"10818","SECONDARY_CAS_RN":"161967-81-3","MESH_SUPPLEMENTAL_RECORD_UI":"C075375"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[{"period":"1997-","companyName":"Otsuka","relationship":"Original Developer"}],"pharmacokinetics":{"source":"DrugCentral","halfLife":"9.2 hours","clearance":"5.9 mL/min/kg","bioavailability":"70%","fractionUnbound":"0.82%"},"publicationCount":313,"therapeuticAreas":["Infectious Disease"],"atcClassification":{"source":"DrugCentral","atcCode":"J01MA11","allCodes":["J01MA11"]},"biosimilarFilings":[],"originalDeveloper":"Otsuka","recentPublications":[{"date":"2024 Jun","pmid":"38291012","title":"Reactive metabolite of trovafloxacin activates inflammasomes: Implications for trovafloxacin-induced liver injury.","journal":"Journal of applied toxicology : JAT"},{"date":"2021 Nov 1","pmid":"34298344","title":"Monitoring of pharmaceuticals in aquatic biota (Procambarus clarkii) of the Doñana National Park (Spain).","journal":"Journal of environmental management"},{"date":"2020 Jun","pmid":"32146702","title":"Fluoroquinolone-Induced Photosensitivity: A Chemical Fragment-Based Approach by a Case/Non-case Study in VigiBase(®).","journal":"Drug safety"},{"date":"2018 Oct 25","pmid":"30086507","title":"Multiresidue determination of 21 pharmaceuticals in crayfish (Procambarus clarkii) using enzymatic microwave-assisted liquid extraction and ultrahigh-performance liquid chromatography-triple quadrupole mass spectrometry analysis.","journal":"Journal of pharmaceutical and biomedical analysis"}],"companionDiagnostics":[],"genericManufacturers":0,"_genericFilersChecked":true,"genericManufacturerList":[],"status":"withdrawn","companyName":"Otsuka","companyId":"otsuka","modality":"Small molecule","firstApprovalDate":"1997","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1997-11-06T00:00:00.000Z","mah":"OTSUKA","brand_name_local":null,"application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T03:26:49.640490+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}